-
1
المؤلفون: Philip C. Amrein, William Blum, Peter M. Voorhees, Daniel J. DeAngelo, Martha Wadleigh, Eyal C. Attar, Richard Stone, Clara D. Bloomfield, Jonathan E. Kolitz, Bayard L. Powell, Guido Marcucci, Jeffrey L. Johnson, Richard A. Larson, Barry K. Moser, Gerard Lozanski, Eunice S. Wang
المصدر: Journal of Clinical Oncology. 31:923-929
مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Myeloid, Daunorubicin, Pharmacology, Disease-Free Survival, Drug Administration Schedule, Bortezomib, immune system diseases, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Peripheral Nervous System, Original Reports, medicine, Humans, neoplasms, Aged, business.industry, Remission Induction, Cytarabine, Histocompatibility Antigens Class II, Myeloid leukemia, Induction chemotherapy, Drug Synergism, Consolidation Chemotherapy, Induction Chemotherapy, Middle Aged, medicine.disease, Boronic Acids, Survival Analysis, Antigens, Differentiation, B-Lymphocyte, Leukemia, Myeloid, Acute, Leukemia, Treatment Outcome, medicine.anatomical_structure, Pyrazines, Female, business, Follow-Up Studies, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b696602fd20ca4ffdebb64f5c9c2e3Test
https://doi.org/10.1200/jco.2012.45.2177Test -
2
المؤلفون: Michael D. Radmacher, Sebastian Schwind, Kati Maharry, Susan P. Whitman, Klaus H. Metzeler, Joseph O. Moore, Richard A. Larson, Deedra Nicolet, Meir Wetzler, Andrew J. Carroll, Heiko Becker, Krzysztof Mrózek, Jihane Khalife, Michael A. Caligiuri, Jessica Kohlschmidt, Maria R. Baer, Jonathan E. Kolitz, Bayard L. Powell, Guido Marcucci, Jason H. Mendler, Thomas H. Carter, Clara D. Bloomfield
المصدر: Journal of Clinical Oncology. 30:3109-3118
مصطلحات موضوعية: Male, Oncology, Cancer Research, Time Factors, DNA Mutational Analysis, Kaplan-Meier Estimate, Gene mutation, medicine.disease_cause, Polymerase Chain Reaction, Risk Factors, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, CEBPA, Oligonucleotide Array Sequence Analysis, Aged, 80 and over, Mutation, Age Factors, Middle Aged, Gene Expression Regulation, Neoplastic, Leukemia, Myeloid, Acute, Leukemia, Phenotype, Treatment Outcome, Core Binding Factor Alpha 2 Subunit, Cytogenetic Analysis, Disease Progression, Female, Nucleophosmin, medicine.drug, Adult, NPM1, medicine.medical_specialty, Adolescent, Risk Assessment, Disease-Free Survival, Young Adult, Internal medicine, Original Reports, medicine, Humans, Genetic Predisposition to Disease, Aged, Proportional Hazards Models, business.industry, Gene Expression Profiling, Cancer, medicine.disease, United States, Gene expression profiling, MicroRNAs, Logistic Models, Multivariate Analysis, Immunology, Cytarabine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d8ab2fdbf5d77af99cbd8e013b6ec89Test
https://doi.org/10.1200/jco.2011.40.6652Test -
3
المؤلفون: Meir Wetzler, John Curfman, Michael A. Caligiuri, Heiko Becker, Sebastian Schwind, Klaus H. Metzeler, Joseph O. Moore, Dean Margeson, Richard A. Larson, Kati Maharry, Susan P. Whitman, Thomas H. Carter, Maria R. Baer, William Blum, Andrew J. Carroll, Yue-Zhong Wu, Jonathan E. Kolitz, Bayard L. Powell, Kelsi B. Holland, Clara D. Bloomfield, Michael D. Radmacher, Krzysztof Mrózek, Guido Marcucci
المصدر: Journal of Clinical Oncology. 29:1373-1381
مصطلحات موضوعية: Male, Oncology, Cancer Research, Time Factors, DNA Mutational Analysis, Kaplan-Meier Estimate, Gene mutation, Bioinformatics, Polymerase Chain Reaction, European LeukemiaNet, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, CEBPA, Medicine, Aged, 80 and over, Gene Expression Regulation, Leukemic, Myeloid leukemia, Middle Aged, DNA-Binding Proteins, Leukemia, Myeloid, Acute, Leukemia, Phenotype, Treatment Outcome, Cytogenetic Analysis, Female, Nucleophosmin, Adult, medicine.medical_specialty, NPM1, Adolescent, Risk Assessment, Disease-Free Survival, Dioxygenases, Young Adult, Proto-Oncogene Proteins, Internal medicine, Original Reports, Humans, Genetic Predisposition to Disease, Aged, Proportional Hazards Models, business.industry, Proportional hazards model, Gene Expression Profiling, Cancer, medicine.disease, United States, MicroRNAs, Mutation, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af7dd6f3005873d64eb3574c86c4d60fTest
https://doi.org/10.1200/jco.2010.32.7742Test -
4
المؤلفون: John Curfman, Heiko Becker, Alison Walker, William Blum, Shujun Liu, Cheryl Kefauver, Larry J. Schaaf, Ramiro Garzon, Jon Mickle, Susan P. Whitman, John C. Byrd, Rebecca B. Klisovic, Jason C. Chandler, Steven M. Devine, Guido Marcucci, Mitch A. Phelps, Xiaoxia Yang, Michael R. Grever, Darlene M. Rozewski
المصدر: Journal of Clinical Oncology. 28:4919-4925
مصطلحات موضوعية: Adult, Oncology, Cancer Research, medicine.medical_specialty, Myeloid, Sialic Acid Binding Ig-like Lectin 3, Antigens, Differentiation, Myelomonocytic, Antineoplastic Agents, Refractory, Antigens, CD, Recurrence, hemic and lymphatic diseases, Internal medicine, Original Reports, medicine, Humans, Lenalidomide, Aged, Aged, 80 and over, Acute leukemia, business.industry, Myelodysplastic syndromes, Myeloid leukemia, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, medicine.disease, Thalidomide, Surgery, Leukemia, Myeloid, Acute, Leukemia, medicine.anatomical_structure, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f13d3341e7e60773f2a4de8a70ac1b55Test
https://doi.org/10.1200/jco.2010.30.3339Test -
5
المؤلفون: Clara D. Bloomfield, Thomas H. Carter, Andrew J. Carroll, Michael A. Caligiuri, Meir Wetzler, Heiko Becker, Sebastian Schwind, Dean Margeson, Maria R. Baer, Susan P. Whitman, Richard A. Larson, Jonathan E. Kolitz, Michael D. Radmacher, Yue-Zhong Wu, Bayard L. Powell, Guido Marcucci, Peter Paschka, Krzysztof Mrózek, Kati Maharry
المصدر: Journal of Clinical Oncology. 28:596-604
مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, NPM1, Internal medicine, Original Reports, CEBPA, Biomarkers, Tumor, medicine, Humans, WT1 Proteins, Survival rate, BAALC, Aged, Neoplasm Staging, Oligonucleotide Array Sequence Analysis, Aged, 80 and over, Gene Expression Regulation, Leukemic, business.industry, Gene Expression Profiling, Remission Induction, Nuclear Proteins, Myeloid leukemia, Cancer, Middle Aged, Prognosis, medicine.disease, Survival Rate, Leukemia, Myeloid, Acute, MicroRNAs, Leukemia, Treatment Outcome, fms-Like Tyrosine Kinase 3, Karyotyping, Mutation, Fms-Like Tyrosine Kinase 3, CCAAT-Enhancer-Binding Proteins, Cancer research, Female, business, Nucleophosmin
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fca9b7c076e563da3cfeeb4636e3d0dTest
https://doi.org/10.1200/jco.2009.25.1496Test -
6
المؤلفون: James W. Vardiman, Mark J. Pettenati, Charles A. Schiffer, Bayard L. Powell, Andrew J. Carroll, Robert J. Mayer, Kati Maharry, Jonathan E. Kolitz, Clara D. Bloomfield, Amy S. Ruppert, Richard A. Larson, Guido Marcucci, Joseph O. Moore, Colin G. Edwards, Krzysztof Mrózek, Lisa J. Sterling
المصدر: Journal of Clinical Oncology. 23:5705-5717
مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Aziridines, Statistics, Nonparametric, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Benzoquinones, Humans, Medicine, Cumulative incidence, Prospective Studies, Prospective cohort study, Cyclophosphamide, Core binding factor acute myeloid leukemia, Survival analysis, Aged, Etoposide, Proportional Hazards Models, Chromosome Aberrations, business.industry, Daunorubicin, Remission Induction, Hazard ratio, Cytarabine, Myeloid leukemia, Cancer, Middle Aged, Prognosis, medicine.disease, Survival Analysis, Leukemia, Leukemia, Myeloid, Acute Disease, Immunology, Female, Mitoxantrone, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b916b1d76136fed7938d1dd13ddef226Test
https://doi.org/10.1200/jco.2005.15.610Test